14-day Premium Trial Subscription Try For FreeTry Free
$1.99
+0.0600 (+3.11%)
At Close: May 01, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $1.83 $2.57 Wednesday, 1st May 2024 CGEN stock ended at $1.99. This is 3.11% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 9.33% from a day low at $1.88 to a day high of $2.05.
90 days $1.83 $3.03
52 weeks $0.530 $3.03

Historical Compugen Ltd. prices

Date Open High Low Close Volume
May 03, 2023 $0.620 $0.638 $0.595 $0.629 124 630
May 02, 2023 $0.590 $0.620 $0.571 $0.610 136 535
May 01, 2023 $0.600 $0.623 $0.553 $0.565 300 688
Apr 28, 2023 $0.586 $0.610 $0.570 $0.590 202 051
Apr 27, 2023 $0.590 $0.607 $0.580 $0.588 132 173
Apr 26, 2023 $0.600 $0.610 $0.570 $0.590 288 691
Apr 25, 2023 $0.610 $0.610 $0.581 $0.600 98 015
Apr 24, 2023 $0.618 $0.619 $0.595 $0.610 112 151
Apr 21, 2023 $0.620 $0.640 $0.605 $0.620 145 580
Apr 20, 2023 $0.640 $0.640 $0.616 $0.620 147 201
Apr 19, 2023 $0.640 $0.647 $0.610 $0.640 90 264
Apr 18, 2023 $0.650 $0.657 $0.630 $0.640 133 463
Apr 17, 2023 $0.637 $0.679 $0.614 $0.640 153 503
Apr 14, 2023 $0.630 $0.650 $0.611 $0.635 138 077
Apr 13, 2023 $0.608 $0.628 $0.591 $0.624 179 816
Apr 12, 2023 $0.630 $0.650 $0.560 $0.590 428 421
Apr 11, 2023 $0.650 $0.670 $0.601 $0.621 293 785
Apr 10, 2023 $0.663 $0.663 $0.603 $0.630 256 757
Apr 06, 2023 $0.660 $0.663 $0.637 $0.655 133 877
Apr 05, 2023 $0.644 $0.701 $0.630 $0.658 104 508
Apr 04, 2023 $0.670 $0.680 $0.601 $0.630 477 551
Apr 03, 2023 $0.700 $0.710 $0.610 $0.670 323 528
Mar 31, 2023 $0.710 $0.736 $0.700 $0.702 80 533
Mar 30, 2023 $0.700 $0.740 $0.700 $0.720 161 172
Mar 29, 2023 $0.721 $0.740 $0.701 $0.712 186 109
Click to get the best stock tips daily for free!

About Compugen Ltd.

Compugen Ltd. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi... CGEN Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT